Yıl: 2009 Cilt: 17 Sayı: 1 Sayfa Aralığı: 36 - 39 Metin Dili: Türkçe İndeks Tarihi: 29-07-2022

Pulmonary carcinosarcomas: An evaluation of seven patients

Öz:
Amaç: Karsinosarkom, akciğerin nadir görülen malign mikst bir tümörüdür. Bu çalışmada bu tümörün tanı, tedavi ve prognozu klinik ve histolojik özellikleriyle birlikte değerlendirildi. Çalışma planı: Çalışmada, ameliyat sonrası histopatolojik tanıları pulmoner karsinosarkom olarak konan yedi hasta (hepsi erkek; ort. yaş 60; dağılım 55-73) incelendi. Hastaların en sık başvuru nedeni öksürük (%57) idi. Uygulanan ameliyatlar iki olguda üst lobektomi, iki olguda pnömonektomi, bir olguda alt lobektomi, bir olguda sleeve üst lobektomi ve bir olguda sadece eksplorasyondu.Bulgular: Ameliyat sonrası patolojik incelemede sleeve üst lobektomi uygulanan hastada pozitif cerrahi sınır bildirildi. Histolojik olarak, epitelyal özellikler bakımından dört tümör skuamöz hücreli karsinom, iki tümör adenokarsinom, bir tümör adenoskuamöz karsinom ile uyumlu bulundu. Sarkomatöz komponent açısından ise üç tümör rabdomiyoblastik, iki tümör kondrosarkomatöz, iki tümör de osteosarkomatöz tipteydi. Tümör evresi iki hastada IB, iki hastada IIB, iki hastada IIIA, bir hastada IIIB bulundu. Lenf nodu metastazı beş hastada saptandı; bunların ikisinde bölgesel (N1), üçünde mediastinal (N2) lenf nodu tutulumu vardı. Ameliyat sonrası erken dönemde ölüm gözlenmedi. Komplikasyon olarak iki olguda uzamış hava kaçağı görüldü. Uzun dönem takipte, bir hasta 14. ayda kranyum metastazı, bir hasta da 21. ayda miyokad infarktüsü nedeniyle kaybedildi. Diğer olgular 6 ay ile 103 ay arasında değişen takip süresi içinde hastalıksızdı. Hastaların ortalama sağkalım süresi 66 ay, bir yıllık ve beş yıllık sağkalım oranları sırasıyla %80 ve %57 olarak hesaplandı.Sonuç: Erken evre pulmoner karsinosarkom tedavisinde komplet cerrahi rezeksiyon en seçkin yöntemdir. N2 hastalık varlığı, cerrahi uygulanmış karsinosarkomlu hastalarda kötü prognostik faktörlerdendir.
Anahtar Kelime: Akciğer neoplazmları Seyir Sağkalım oranı Karsinosarkom

Konular: Kalp ve Kalp Damar Sistemi Cerrahi

Pulmoner karsinosarkom: Yedi olgunun değerlendirilmesi

Öz:
Background: Carcinosarcoma is a rare malignant mixed tumor of the lungs. We evaluated the diagnosis, treatment, and prognosis of this tumor along with the clinical and histological features. Methods: The study included seven patients (all males; mean age 60 years; range 55 to 73 years) whose postoperative histopathologic diagnosis was pulmonary carcinosarcoma. The most common presenting symptom was cough (57%). Operations performed were upper lobectomy (n=2), pneumonectomy (n=2), lower lobectomy (n=1), sleeve upper lobectomy (n=1), and only exploration (n=1).Results: Postoperative pathological examination showed positive margins in the patient treated with sleeve upper lobectomy. Histologically, epithelial characteristics of the tumors were consistent with squamous cell carcinoma (n=4), adenocarcinoma (n=2), and adenosquamous carcinoma (n=1). The sarcomatous component was of rhabdomyoblastic type in three, chondrosarcomatous type in two, and osteosarcomatous type in two tumors. Two patients had stage IB, two patients had IIB, two patients had IIIA, and one patient had IIIB tumors. Five patients had lymph node metastasis, involving the regional lymph nodes (N1) in two patients, and mediastinal lymph nodes (N2) in three patients. No mortality occurred in the early postoperative period. Two patients had prolonged air leak postoperatively. One patient died in the postoperative 14th month due to cranium metastasis and another patient died of myocardial infarction in the postoperative 21st month. The other patients were disease-free during a follow-up period of 6 to 103 months. The mean survival was estimated as 66 months, with one-year survival being 80% and five-year survival being 57%.Conclusion: Complete surgical resection is the treatment of choice for early stage pulmonary carcinosarcoma. N2 disease is an unfavorable prognostic factor in patients with carcinosarcoma.
Anahtar Kelime: Carcinosarcoma Lung Neoplasms Prognosis Survival Rate

Konular: Kalp ve Kalp Damar Sistemi Cerrahi
Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1) Davis MP, Eagan RT, Weiland LH, Pairolero PC. Carcinosarcoma of the lung: Mayo Clinic experience and response to chemotherapy. Mayo Clin Proc 1984;59:598-603.
  • 2) Huwer H, Kalweit G, Straub U, Feindt P, Volkmer I, Gams E. Pulmonary carcinosarcoma: diagnostic problems and determinants of the prognosis. Eur J Cardiothorac Surg 1996; 10:403-7.
  • 3) Ferrando C, Piédrola G, Pérez-Rodriguez E, Fogué L, Zapatero J, Flandes J, et al. Gigant carcinosarcoma. Respiration 1992; 59:351-4.
  • 4) Guarino M, Tricomi P, Giordano F, Cristofori E. Sarcomatoid carcinomas: pathological and histopathogenetic considerations. Pathology 1996;28:298-305.
  • 5) Nakajima M, Kasai T, Hashimoto H, Iwata Y, Manabe H. Sarcomatoid carcinoma of the lung: a clinicopathologic study of 37 cases. Cancer 1999;86:608-16.
  • 6) Koss MN, Hochholzer L, Frommelt RA. Carcinosarcomas of the lung: a clinicopathologic study of 66 patients. Am J Surg Pathol 1999;23:1514-26.
  • 7) Takeda S, Nanjo S, Nakamoto K, Imachi T, Yamamoto S. Carcinosarcoma of the lung. Report of a case and review of the literature. Respiration 1994;61:113 6.
  • 8) Cohen-Salmon D, Michel RP, Wang NS, Eddy D, Hanson R. Pulmonary carcinosarcoma and carcinoma: report of a case studied by electron microscopy, with critical review of the literature. Ann Pathol 1985;5:115-24.
  • 9) Moore TC. Carcinosarcoma of the lung. Surgery 1961; 50:886-93.
  • 10) Humphrey PA, Scroggs MW, Roggli VL, Shelburne JD. Pulmonary carcinomas with a sarcomatoid element: an immunocytochemical and ultrastructural analysis. Hum Pathol 1988;19:155-65.
  • 11) Stackhouse EM, Harrison EG Jr, Ellis FH Jr. Primary mixed malignancies of lung: carcinosarcoma and blastoma. J Thorac Cardiovasc Surg 1969;57:385-99.
  • 12) Kim KI, Flint JD, Müller NL. Pulmonary carcinosarcoma: radiologic and pathologic findings in three patients. AJR Am J Roentgenol 1997;169:691-4.
  • 13) Fishback NF, Travis WD, Moran CA, Guinee DG Jr, McCarthy WF, Koss MN. Pleomorphic (spindle/giant cell) carcinoma of the lung. A clinicopathologic correlation of 78 cases. Cancer 1994;73:2936-45.
  • 14) Rainosek DE, Ro JY, Ordonez NG, Kulaga AD, Ayala AG. Sarcomatoid carcinoma of the lung. A case with atypical carcinoid and rhabdomyosarcomatous components. Am J Clin Pathol 1994;102:360-4.
  • 15) Langer F, Wintzer HO, Werner M, Weber C, Brümmendorf TH, Bokemeyer C. A case of pulmonary carcinosarcoma (squamous cell carcinoma and osteosarcoma) treated with cisplatin and doxorubicin. Anticancer Res 2006;26:3893-7.
  • 16) Petrov DB, Vlassov VI, Kalaydjiev GT, Plochev MA, Obretenov ED, Stanoev VI, et al. Primary pulmonary sarcomas and carcinosarcomas- postoperative results and comparative survival analysis. Eur J Cardiothorac Surg 2003;23:461 6.
  • 17) Xu Z, Ding J, Shi M. Lung carcinosarcoma-a report of 15 cases. Zhonghua Zhong Liu Za Zhi 1996;18:119-22. [Abstract]
APA YAZICI Ü, TAŞTEPE İ, GÜLHAN E, EGE T, DEMİRAĞ F, Kaya S, Altinok T (2009). Pulmonary carcinosarcomas: An evaluation of seven patients. , 36 - 39.
Chicago YAZICI Ülkü,TAŞTEPE İrfan,GÜLHAN Erkmen,EGE Taner,DEMİRAĞ Funda,Kaya Sadi,Altinok Tamer Pulmonary carcinosarcomas: An evaluation of seven patients. (2009): 36 - 39.
MLA YAZICI Ülkü,TAŞTEPE İrfan,GÜLHAN Erkmen,EGE Taner,DEMİRAĞ Funda,Kaya Sadi,Altinok Tamer Pulmonary carcinosarcomas: An evaluation of seven patients. , 2009, ss.36 - 39.
AMA YAZICI Ü,TAŞTEPE İ,GÜLHAN E,EGE T,DEMİRAĞ F,Kaya S,Altinok T Pulmonary carcinosarcomas: An evaluation of seven patients. . 2009; 36 - 39.
Vancouver YAZICI Ü,TAŞTEPE İ,GÜLHAN E,EGE T,DEMİRAĞ F,Kaya S,Altinok T Pulmonary carcinosarcomas: An evaluation of seven patients. . 2009; 36 - 39.
IEEE YAZICI Ü,TAŞTEPE İ,GÜLHAN E,EGE T,DEMİRAĞ F,Kaya S,Altinok T "Pulmonary carcinosarcomas: An evaluation of seven patients." , ss.36 - 39, 2009.
ISNAD YAZICI, Ülkü vd. "Pulmonary carcinosarcomas: An evaluation of seven patients". (2009), 36-39.
APA YAZICI Ü, TAŞTEPE İ, GÜLHAN E, EGE T, DEMİRAĞ F, Kaya S, Altinok T (2009). Pulmonary carcinosarcomas: An evaluation of seven patients. Türk Göğüs Kalp Damar Cerrahisi Dergisi, 17(1), 36 - 39.
Chicago YAZICI Ülkü,TAŞTEPE İrfan,GÜLHAN Erkmen,EGE Taner,DEMİRAĞ Funda,Kaya Sadi,Altinok Tamer Pulmonary carcinosarcomas: An evaluation of seven patients. Türk Göğüs Kalp Damar Cerrahisi Dergisi 17, no.1 (2009): 36 - 39.
MLA YAZICI Ülkü,TAŞTEPE İrfan,GÜLHAN Erkmen,EGE Taner,DEMİRAĞ Funda,Kaya Sadi,Altinok Tamer Pulmonary carcinosarcomas: An evaluation of seven patients. Türk Göğüs Kalp Damar Cerrahisi Dergisi, vol.17, no.1, 2009, ss.36 - 39.
AMA YAZICI Ü,TAŞTEPE İ,GÜLHAN E,EGE T,DEMİRAĞ F,Kaya S,Altinok T Pulmonary carcinosarcomas: An evaluation of seven patients. Türk Göğüs Kalp Damar Cerrahisi Dergisi. 2009; 17(1): 36 - 39.
Vancouver YAZICI Ü,TAŞTEPE İ,GÜLHAN E,EGE T,DEMİRAĞ F,Kaya S,Altinok T Pulmonary carcinosarcomas: An evaluation of seven patients. Türk Göğüs Kalp Damar Cerrahisi Dergisi. 2009; 17(1): 36 - 39.
IEEE YAZICI Ü,TAŞTEPE İ,GÜLHAN E,EGE T,DEMİRAĞ F,Kaya S,Altinok T "Pulmonary carcinosarcomas: An evaluation of seven patients." Türk Göğüs Kalp Damar Cerrahisi Dergisi, 17, ss.36 - 39, 2009.
ISNAD YAZICI, Ülkü vd. "Pulmonary carcinosarcomas: An evaluation of seven patients". Türk Göğüs Kalp Damar Cerrahisi Dergisi 17/1 (2009), 36-39.